138971-00-3

Upstream product

• 138457-44-0 (4R,5R)-5-(2,4-Difluorophenyl)-4-methyl-5-<(1H-1,2,4-triazol-1-yl)methyl>oxazolidine 
• 126916-45-8 (4R*,5R*)-5-(2,4-Difluorophenyl)-4-methyl-5-<(1H-1,2,4-triazol-1-yl)methyl>oxazolidine 

Downstream Products

• 138990-36-0 N-[(1S,2S)-2-(2,4-Difluoro-phenyl)-2-hydroxy-1-methyl-3-[1,2,4]triazol-1-yl-propyl]-N-methyl-4-trifluoromethyl-benzamide 
• 126918-11-4 N-[(1S,2S)-2-(2,4-Difluoro-phenyl)-2-hydroxy-1-methyl-3-[1,2,4]triazol-1-yl-propyl]-N-methyl-3-trifluoromethyl-benzamide 
• 138989-94-3 (2R,3R)-2-(2,4-Difluorophenyl)-3-amino>-1-(1H-1,2,4-triazol-1-yl)-2-butanol 
• 126917-09-7 (E)-3-(4-Chloro-phenyl)-N-[(1S,2S)-2-(2,4-difluoro-phenyl)-2-hydroxy-1-methyl-3-[1,2,4]triazol-1-yl-propyl]-N-methyl-acrylamide 

Relevant academic research and scientific papers

Triazole antifungals. IV. Synthesis and antifungal activities of 3-acylamino-2-aryl-2-butanol derivatives

New triazole compounds were designed and synthesized as potential inhibitors of the fungal cytochrome P-450 14α-demethylase. In testing for antifungal activity against a mouse systemic Candida albicans infection, (2R,3R)3-acylamino-2-aryl-2-butanol deriva